Range Financial Group
JAZZ icon

Range Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Range Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.79M Sell
7,712
-230
-3% -$56.8K 0.5% 62
2026
Q2 		$1.91M Sell
7,942
-35
-0.4% -$7.67K 0.52% 61
2026
Q1 		$1.51M Buy
7,977
+205
+3% +$35.8K 0.51% 68
2025
Q4 		$1.32M Sell
7,772
-307
-4% -$47.1K 0.46% 71
2025
Q3 		$1.06M Buy
8,079
+703
+10% +$84.3K 0.38% 81
2025
Q2 		$783K Sell
7,376
-9
-0.1% -$978 0.31% 99
2025
Q1 		$917K Buy
+7,385
New +$963K 0.41% 79

Other funds holding JAZZ

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Range Financial Group's JAZZ Position: Q3 2026 in Review

Range Financial Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.9% in Q3 2026, selling an estimated $56.8K and leaving 7,712 shares worth $1.79M. The position accounts for 0.5% of the portfolio, ranked #62.

Range Financial Group first reported a position in JAZZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.91M in Q2 2026. 119 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Range Financial Group held 7,712 shares of Jazz Pharmaceuticals worth $1.79M as of Q3 2026.
  • Range Financial Group sold 230 Jazz Pharmaceuticals shares in Q3 2026, an estimated $56.8K.
  • Jazz Pharmaceuticals made up 0.5% of Range Financial Group's portfolio in Q3 2026, its #62 holding.
  • Range Financial Group first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Range Financial Group's Jazz Pharmaceuticals position peaked at $1.91M in Q2 2026.
  • 119 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.